A share price of PDS Biotechnology Corporation [PDSB] is currently trading at $1.53, up 8.51%. An important factor to consider is whether the stock is rising or falling in short-term value. The PDSB shares have gain 6.99% over the last week, with a monthly amount glided 10.87%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
PDS Biotechnology Corporation [NASDAQ: PDSB] stock has seen the most recent analyst activity on November 01, 2022, when B. Riley Securities initiated its Buy rating and assigned the stock a price target of $10. Previously, Cantor Fitzgerald started tracking the stock with Overweight rating on June 28, 2021, and set its price target to $25. On November 10, 2020, upgrade upgraded it’s rating to Buy but maintained its price target of $6 on the stock. Alliance Global Partners started tracking the stock assigning a Buy rating and suggested a price target of $4 on May 27, 2020. Noble Capital Markets initiated its recommendation with a Outperform and recommended $5.45 as its price target on March 09, 2020. Chardan Capital Markets started tracking with a Buy rating for this stock on October 24, 2019, and assigned it a price target of $10.
PDS Biotechnology Corporation experienced fluctuations in its stock price throughout the past year between $0.85 and $4.42. Currently, Wall Street analysts expect the stock to reach $9 within the next 12 months. PDS Biotechnology Corporation [NASDAQ: PDSB] shares were valued at $1.53 at the most recent close of the market. An investor can expect a potential return of 488.24% based on the average PDSB price forecast.
Analyzing the PDSB fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.75, Equity is -1.51 and Total Capital is -1.23. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.85.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.4300 points at the first support level, and at 1.3300 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.5800, and for the 2nd resistance point, it is at 1.6300.
Ratios To Look Out For
To put it in perspective, the Current Ratio for PDS Biotechnology Corporation [NASDAQ:PDSB] is 2.33. On the other hand, the Quick Ratio is 2.33, and the Cash Ratio is 2.19.
Transactions by insiders
Recent insider trading involved Freitag Gregory Gene, Director, that happened on Feb 28 ’25 when 15060.0 shares were purchased. Director, Glover Stephen C. completed a deal on Feb 28 ’25 to buy 15061.0 shares.
